EnerSyn Global (ESYN) vs McKesson (MCK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
McKesson (MCK) has outperformed EnerSyn Global (ESYN) over the past year, gaining 21.4% versus a loss of 27.2%. McKesson is the larger company by market cap ($106.14 billion vs $61.2 million), about 1733.2 times the size. McKesson pays a dividend yielding 0.36%, while EnerSyn Global does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESYN | MCK |
|---|---|---|
| Share price | $2.06 | $910.33 |
| Market cap | $61.24M | $106.14B |
| 1-day change | -1.90% | -1.23% |
| YTD return | +38.26% | +10.98% |
| 1-year return | -27.21% | +21.36% |
| 5-year return | — | +345.87% |
| P/E ratio (TTM) | — | 24.24 |
| Forward P/E | — | 18.04 |
| EPS (TTM) | $-0.39 | $37.56 |
| Dividend yield | 0.00% | 0.36% |
| Annual dividend | $0.00 | $3.28 |
| Revenue (latest FY) | — | $403.43B |
| Revenue growth (YoY) | — | +12.36% |
| Net income (latest FY) | — | $4.76B |
| Gross margin | — | 3.61% |
| Operating margin | — | 1.54% |
| Net margin | — | 1.18% |
| 52-week high | $2.81 | $999.00 |
| 52-week low | $0.88 | $723.68 |
| Distance from 52-week high | -26.69% | -8.88% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +7.36% |
| Average volume | 164.43K | 924.58K |
| Shares outstanding | 29.73M | 116.59M |
| Employees | — | 41,600 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 1733.2 times larger than EnerSyn Global by market value ($106.14B vs $61.24M).
- MCK has outperformed ESYN by 48.6 percentage points over the past year.
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
ESYN vs MCK FAQ
Which is bigger, EnerSyn Global or McKesson?
McKesson (MCK) is larger, with a market capitalization of $106.14B compared with $61.24M for EnerSyn Global (ESYN).
Which stock has performed better over the past year, ESYN or MCK?
MCK returned +21.36% over the past 12 months, compared with -27.21% for ESYN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, EnerSyn Global or McKesson?
McKesson pays a dividend yielding 0.36%, while EnerSyn Global does not currently pay a regular dividend.
Are EnerSyn Global and McKesson in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.